After closing two mega-rounds of investment within eight months of each other, a booming Rubius Therapeutics has just set terms for a $200 million IPO.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,